Analysts reduced HCA Healthcare’s 2026-2027 growth forecasts after a survey indicated flat revenue and weaker surgical volumes.
TD Cowen cut HCA Healthcare’s (HCA) price target to $431 from $500 while maintaining a Buy rating. The adjustment follows a May hospital survey showing flat year-over-year revenue and softer surgical volumes, partially offset by medical volume growth.
The firm lowered its 2026 and 2027 growth assumptions for HCA, citing the survey’s findings. Prior estimates had reflected higher expectations, but recent data prompted the revision.
HCA Healthcare also announced plans to acquire The College of Health Care Professions, expanding its workforce development efforts. The deal underscores HCA’s focus on education and clinical partnerships.